Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.St Jude Medical, a medical device company, has received the European CE Mark approval for its Genesis neurostimulation system for managing a form of chest pain known as chronic angina pectoris, or chronic angina.
Subscribe to our email newsletter
In addition to chronic angina, the Genesis neurostimulation system is approved for treating chronic neuropathic pain of the trunk and limbs and pain from back surgeries that have failed.
Approximately the size of a stopwatch, this neurostimulation system helps to control angina pain by sending mild pulses of electricity from a device implanted in the torso via thin insulated wires called leads to nerves located along the spinal cord, the company said.
Chris Chavez, president of neuromodulation division at St Jude Medical, said: “This approval is an important step forward in being able to provide pain solutions for people who have exhausted most other treatments. Our goal is to continue to develop new applications for our medical technologies and to provide physicians with more options in their choice of treatments.”